InvestorsHub Logo
Followers 52
Posts 5314
Boards Moderated 0
Alias Born 09/16/2013

Re: KIPK post# 665446

Saturday, 01/20/2024 3:04:41 PM

Saturday, January 20, 2024 3:04:41 PM

Post# of 689011
Ultimately one has to conclude BP will pay handsomely for the pleasure of DCVAX... one way (partnership, licensing) or another (buyout). Don't forget, LP has over 15 years of experience in corporate finance and restructurings, mergers and acquisitions, joint ventures, and intellectual property licensing. Now that DCVax has been proven efficacious, the party starts from this point on where LP can utilize her super-powers. Pay they will.




Past experience with other M & A that the current NWBO valuation is based on is meaningless IMO, unless the scope of their potential applications & the expected (hoped for) outcome is analyzed & critically considered.
The KITE, JUNO examples that are given at about $13B acquisition range were based on hope/potential only & the CAR-T stuff as a whole for solid tumors ended up being too expensive, having major side effects, ineffective and basically been discarded!!

NWBO technology has become de-risked, its broad application potentials have been documented & future expansions are reasonably predictable,
I wonder where is will end up & how much a self-aware big name pharma would be willing to pay for it??

Bullish
Bullish

Anyone who can make you believe absurdities can make you commit atrocities-- Voltaire

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News